dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Angeles, Martina Aida |
dc.contributor.author | Cabarrou, Bastien |
dc.contributor.author | Gil Moreno, Antonio |
dc.contributor.author | Perez Benavente, Maria Asuncion |
dc.contributor.author | Spagnolo, Emanuela |
dc.contributor.author | Rychlik, Agnieszka |
dc.date.accessioned | 2022-04-25T14:59:20Z |
dc.date.available | 2022-04-25T14:59:20Z |
dc.date.issued | 2021-11 |
dc.identifier.citation | Angeles MA, Cabarrou B, Gil-Moreno A, Pérez-Benavente A, Spagnolo E, Rychlik A, et al. Effect of tumor burden and radical surgery on survival difference between upfront, early interval or delayed cytoreductive surgery in ovarian cancer. J Gynecol Oncol. 2021 Nov;32(6):e78. |
dc.identifier.issn | 2005-0399 |
dc.identifier.uri | https://hdl.handle.net/11351/7408 |
dc.description | Procediments quirúrgics de citoreducció; Teràpia neoadjuvant; Neoplàsies d'ovari |
dc.description.sponsorship | The project that gave rise to these results received the support of a fellowship from “la Caixa” Foundation (ID 100010434). The fellowship code is LCF/BQ/EU18/11650038. |
dc.language.iso | eng |
dc.publisher | Korean Society of Gynecologic Oncology & Colposcopy |
dc.relation.ispartofseries | Journal of Gynecologic Oncology;32(6) |
dc.rights | Attribution-NonCommercial 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ |
dc.source | Scientia |
dc.subject | Ovaris - Càncer - Cirurgia |
dc.subject | Quimioteràpia combinada |
dc.subject | Marcadors tumorals |
dc.subject.mesh | Ovarian Neoplasms |
dc.subject.mesh | /surgery |
dc.subject.mesh | Chemotherapy, Adjuvant |
dc.subject.mesh | Tumor Burden |
dc.title | Effect of tumor burden and radical surgery on survival difference between upfront, early interval or delayed cytoreductive surgery in ovarian cancer |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3802/jgo.2021.32.e78 |
dc.subject.decs | neoplasias ováricas |
dc.subject.decs | /cirugía |
dc.subject.decs | quimioterapia adyuvante |
dc.subject.decs | carga tumoral |
dc.relation.publishversion | https://doi.org/10.3802/jgo.2021.32.e78 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Angeles MA] Department of Surgical Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse Oncopole (IUCT-Oncopole), Toulouse, France. [Cabarrou B] Biostatistics Unit, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse Oncopole (IUCT-Oncopole), Toulouse, France. [Gil-Moreno A, Pérez-Benavente A] Servei d’Oncologia Ginecològica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Spagnolo E] Gynecologic Oncology Unit, La Paz University Hospital, Instituto de Investigación Hospital Universitario La Paz (IdiPAZ), Madrid, Spain. [Rychlik A] Department of Gynaecologic Oncology, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland |
dc.identifier.pmid | 34431252 |
dc.identifier.wos | 000756151400007 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |